US › Healthcare

Novartis AG ADR (NVS)

US · Healthcare · Drug Manufacturers - General

$153.27-0.26%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$14.42B
Revenue YoY
-2.8%
Net profit
$3.27B
Profit YoY
-19.2%
EPS
$2.41
EPS estimate
$2.20
Net margin
22.7%

EPS came in at 2.41 against a street estimate of 2.20 — a beat of 9.5%.

Key statistics

Market cap
$296.80B
P/E
23.6
Forward P/E
17.5
P/B
7.14
Book value
$21.86
EPS (TTM)
$6.62
Dividend yield
3.04%
52-week high
$165.43
52-week low
$110.13
50-day MA
$152.56
200-day MA
$146.27
Beta
0.49

Analyst view

Analysts rate Novartis AG ADR a hold (2 buy, 9 hold, 2 sell out of 13) with an average price target of $155.37.

Shareholding

Institutions
7.69%

Largest institutional holders

FundStake
Fisher Asset Management, LLC0.73%
Morgan Stanley - Brokerage Accounts0.45%
Dimensional Fund Advisors, Inc.0.43%
PRIMECAP Management Company0.40%
Dodge & Cox0.37%
The Goldman Sachs Group Inc0.34%
Loomis, Sayles & Company LP0.29%
Bank of America Corp0.26%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Novartis AG ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences IncPfizer Inc

Data updated 2026-08-05.